期刊文献+

CIAPIN1基因RNA干扰载体的构建及其对乳腺癌细胞耐药性的影响 被引量:2

Construction of CIAPIN1-RNAi vector and its effect on drug resistance of breast cancer cells
原文传递
导出
摘要 目的:构建针对CIAPIN1基因的慢病毒siRNA表达载体并稳定转染人乳腺癌多柔比星耐药细胞MCF-7/ADM,观察该基因对乳腺癌细胞耐药性的影响。方法:设计合成针对CIAPIN1的siRNA重组质粒表达载体,并筛选出最有效的干扰序列,使用病毒包装系统进行慢病毒颗粒的包装和生产,获取ADM-CIAPIN1 RNAi稳定表达细胞株;MTT法检测CIAPIN1基因干扰前后细胞对于不同化疗药物IC50值的变化。结果:测序验证针对CIAPIN1的siRNA重组质粒构建成功,并筛选CIAP-IN1-siRNA1为最佳干扰序列;以慢病毒为载体将干扰表达质粒稳定转染入乳腺癌细胞MCF-7/ADM后,抑制CIAPIN1表达水平超过88%。RNA干扰后紫杉醇、多柔比星及吉西他滨3种抗肿瘤药物对于MCF-7/ADM细胞的IC50值均显著下降[(7.12±0.31)、(11.21±1.79)、(49.72±4.52)vs(1.13±0.06)、(4.51±0.20)、(18.30±1.27)μg/ml,P<0.01],说明该细胞的耐药性明显减弱。结论:针对CIAPIN1基因的慢病毒siRNA表达载体可以有效抑制MCF-7/ADM细胞中该基因的表达,CIAPIN1基因表达下调可使乳腺癌细胞的多药耐药性发生逆转。 Objective: To construct lentiviral expressed vector of siRNA targeting CIAPIN1 and establish breast cancer cells with a stable expression of siRNA-CIAPIN1,and to investigate the effect of CIAPIN1 on breast cancer cells multi-drug resistance.Methods: The expressed vectors of recombined plasmid of siRNA targeting CIAPIN1 were designed and synthesized.Select the most efficient interfering sequence,spackage,and produce a lentiviral vector with it.Stably transfect CIAPIN1-RNAi into MCF-7/ADM cells.Detect IC50 value of different drugs in MCF-7/ADM cells before and after CIAPIN1 interference by MTT.Results: The expressed vectors of recombined plasmid of siRNA targeting CIAPIN1 were successfully synthesized and the most efficient interfering sequence was CIAPIN1-siRNA1.Stable transfection of CIAPIN1-RNAi into MCF-7/ADM cells by a lentiviral vector suppressed the expression of CIAPIN1 in MCF-7/ADM cells more than 88%.After RNA interference,IC50 value of MCF-7/ADM cells to anticancer drugs(paclitaxel,doxorubicin and gemcitabine) significantly decreased from(7.12±0.31),(11.21±1.79),(49.72±4.52) to(1.13±0.06),(4.51±0.20),(18.30±1.27) μg/ml respectively,suggesting a significant decrease in the drug resisstance of the cells.Conclusion: Lentiviral expressed vector of CIAPIN1-siRNA can efficiently interfere the expression of CIAPIN1 in MCF-7/ADM cells.The study also confirmed the regulation effect of CIAPIN1 on breast cancer cell multi-drug resistance(MDR).
出处 《中国肿瘤生物治疗杂志》 CAS CSCD 北大核心 2012年第1期66-71,共6页 Chinese Journal of Cancer Biotherapy
基金 哈尔滨市科技局科技创新人才研究专项资金项目(No.2009RFQXS028)~~
关键词 乳腺癌 CIAPIN1基因 RNA干扰 多药耐药性 紫杉醇 多柔比星 吉西他滨 breast cancer CIAPIN1 gene RNA interference multi-drug resistance(MDR) paclitaxel doxorubicin gemcitabine
  • 相关文献

参考文献18

  • 1何健荣,高曦,任泽舫.全球女性乳腺癌和卵巢癌最新发病分布特征[J].中国肿瘤,2009,18(3):169-172. 被引量:63
  • 2周向荣,刘兴祥,崔林.每周剂量紫杉醇联合蒽环类药物治疗晚期乳腺癌的临床观察[J].实用临床医药杂志,2010,14(2):57-58. 被引量:7
  • 3Kuo MT.Roles of multidrug resistance genes in breast cancer che-moresistance[J].Adv Exp Med Biol,2007,608N:23-30.
  • 4Hao Z,Li X,Qiao T,et al.Downregulated expression of CIAPIN1may contribute to gastric carciogenesis by accelerating cell prolifer-ation and promoting cell cycle progression[J].Cancer Biol,2009,8(11):1064-1070.
  • 5Shibayama H,Takai E,Matsumura I,et al.Identification of a cy-tokine-induced antiapoptotic molecule anamorsin essential for de-finitive hematopoiesis[J].Exp Med,2004,199(4):581-592.
  • 6Hao Z,Li X,Qiao T,et al.Distribution of CIAPIN1 in normal fe-tal and adult human tissues[J].Histochem Cytochem,2006,54(4):417-426.
  • 7Li X,Wu K,Fan D.CIAPIN1 as a therapeutic target in cancer[J].Expert Opin Ther Targets,2010,14(6):603-610.
  • 8He J,Wang H,Jin H,et al.CIAPIN1 inhibits the growth andproliferation of clear cell renal cell carcinoma[J].Cancer Let-ters,2009,276(1):88-94.
  • 9Hao Z,Li X,Qiao T,et al.CIAPIN1 confers multidrug resistanceby upregulating the expression of MDR-1 and MRP-1 in gastriccancer cells[J].Cancer Biol Ther,2006,5(3):261-266.
  • 10Hannon GJ.RNA interference[J].Nature,2002,418(6894):244-251.

二级参考文献64

  • 1戴春岭,符立梧.肿瘤多药耐药逆转剂的研究进展[J].中国药理学通报,2005,21(5):513-518. 被引量:39
  • 2鲍萍萍,郑莹,李新建,沈玉珍,向詠梅,金凡.利用GM模型分析上海市区女性乳腺癌和卵巢癌发病率[J].中国卫生统计,2005,22(5):299-300. 被引量:16
  • 3魏昌华,姚春芳,恽榴红.新型抗癌药──紫杉醇[J].中国药学杂志,1996,31(5):259-263. 被引量:57
  • 4严婷,张莲芬,张熔熔,冯磊,金坚.人乳腺癌多药耐药细胞系MCF-7/MDR^a的建立及其生物学特性的初步研究[J].细胞生物学杂志,2006,28(4):591-595. 被引量:14
  • 5Kamangar F, Dores GM, Anderson WF. Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world[J]. J Clin Oncol, 2006, 24(14):2137-2150.
  • 6Nkondjock A, Ghadirian P. Risk factors and risk reduction of breast cancer[J]. Med Sci (Paris), 2005, 21(2):175-180.
  • 7Salehi F, Dunfield L, Phillips KP, et al. Risk factors for ovarian cancer: an overview with emphasis on hormonal factors[J]. J Toxicol Environ Health B Crit Rev, 2008, 11 (3-4):301-321.
  • 8Vo C, Carney ME. Ovarian cancer hormonal and environmental risk effect[J]. Obstet Gynecol Clin North Am, 2007, 34(4):687-700.
  • 9Curado MP, Edwards B, Shin HR, et al. Cancer incidence in five continents. Vol.Ⅸ[M]. Lyon: IARC, 2007.
  • 10Lee JH, Yim SH, Won YJ, et al. Population-based breast cancer statistics in Korea during 1993-2002: incidence, mortality, and survival[J]. J Korean Med Sci, 2007, 22 (Suppl):S11-16.

共引文献72

同被引文献27

  • 1He L, Wang H, Jin H, et al. CIAPIN1 inhibits the growth and proliferation of clear cell renal cell carcinoma [ J]. Cancer Lett, 2009, 276(1) : 88 -94.
  • 2Hao Z, Li X, Qiao T, et al. Successful expression and purification of human CIAPIN1 in baculovirus-insect cell system and application of this system to investigation of its potential methyltransferase activity [J]. Int J Biol Macromol, 2008, 42(1): 27-32.
  • 3Hede K. Studies define role of microRNA in cancer [ J]. J Natl Cancer Inst, 2005, 97(15) : 1114 - 1115.
  • 4Wickramasinghe NS, Manavalan TT, Dougherty SM, et al. Estradiol downregulates miR-21 expression and increases miR-21 target gene expression in MCF-7 breast cancer cells [ J]. Nucleic Acids Res, 2009, 37(8) : 2584 -2595.
  • 5Gambari R, Fabbri E, Borgatti M, et al. Targeting microRNAs involved in human diseases: A novel approach for modification of gene expression and drug development [ J ]. Biochem Pharmacol, 2011, 82(10): 1416 -1429.
  • 6Iorio MV, Casalini P, Piovan C, et al. Breast cancer and microRNAs: therapeutic impact [ J ]. Breast, 2011, 20 ( Suppl 3 ) : S63 - S70.
  • 7Si ML, Zhu S, Wu H, et al. MiR-21-mediated tumor growth[J]. Oncogene, 2007, 20(19): 2799-2803.
  • 8Surichan S, Androutsopoulos VP, Sifakis S, et al. Bioactivation of the citrus flavonoid nobiletin by CYP1 enzymes in MCF7 breast adenocarcinoma cells [ J]. Food Chem Toxicol, 2012, 50 (9) : 3320 - 3328.
  • 9Dey N, Liu T, Garofalo RP, et al. Roberto. TAK1 regulates NF-KB and AP-1 activation in airway epithelial ceils following RSV infection [J]. Virology, 2011, 418(2): 93-101.
  • 10Miller TE, Ghoshal K, Ramaswamy B, et al. MicroRNA-221/222 confers tamoxifen resistance in breast cancer by targeting p27 Kip1 [J]. JBiolChem, 2008, 283(44): 29897 -29903.

引证文献2

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部